Supply Chain

“Cold chain” now means cryogenic and ambient shipping, as well as the traditional 2–8° range

Supply chain leaders gather in Philadelphia in October

Global supply chain issues in distribution bring senior execs together

A better way to reverse the cryopreservation common in cellular therapies

A 60% increase in pallet storage capability

First gene therapy product in US; approval expedited by evidence of high cure rates

Investors hope for a repeat of Gilead’s Sovaldi success

Company is targeting a treatment for glioblastoma; Phase I to begin next year

Leading CRO looks to better trial recruitment, outcomes research

Is the accelerated-approval process providing a net benefit to patients?

CEIV Pharma certification; expanded temperature regimes and better calibration capabilities

Oncology, obesity control and respiratory therapy are the first targets

Firm has quintupled its Indianapolis facility over two years

Pharma traceability company will expand global presence

August, December and February meetings target unresolved technical issues

GAO report notes FDA’s 99% acceptance rate for ‘expanded access’, but legislators press on

Managing physician office drug inventory

More serialization options, especially for low-volume pharma manufacturers struggling with the November 2017 deadline

40,000-sq. ft. facility is near Dublin Airport

Completion scheduled for 2019

New DHL report sees transformational trends

Cellular and genetic therapies drive a ‘new paradigm’ for logistics

Novartis’ CTL019 (tisagenlecleucel) has helped nearly 80% of patients who failed chemotherapy for a form of leukemia

Late-June announcement gives industry some breathing room for installing product-serialization systems